NCT04362579

Brief Summary

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 27, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

March 3, 2022

Status Verified

March 1, 2022

Enrollment Period

11 months

First QC Date

April 15, 2020

Last Update Submit

March 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Device comparison to standard monitoring

    The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems.

    2 years

Study Arms (2)

Subjects seen in hospital

Subjects will be recruited from Prentice Women's Hospital inpatient antepartum and labor and delivery services, and the outpatient Obstetrics and Gynecology practice, located within Galter tower with the assistance of staff.

Device: wearable vital signs sensor

Home Study subjects

Subjects will be prescreened by an IRB approved staff and recruited from Prentice Women's Hospital's Department of Obstetrics and Gynecology.

Device: wearable vital signs sensor

Interventions

vital signs monitoring during maternal non-stress testing or in the home setting

Home Study subjectsSubjects seen in hospital

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women

You may not qualify if:

  • Women who refuse to signed the informed consent form
  • Maternal age under 18 years old
  • Multiple pregnancy
  • Known major fetal malformation or chromosomal abnormality
  • Medical or obstetric problem that would preclude the use of abdominal electrodes
  • Inability to consent to this study due to medical illness, diminished intellectual capacity, or language barrier
  • Women using pacemakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

Location

Study Officials

  • Shuai Xu, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2020

First Posted

April 27, 2020

Study Start

January 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

March 3, 2022

Record last verified: 2022-03

Locations